Reproductive Outcomes After Methotrexate Therapy for Ectopic Pregnancy
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 94
فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JOGCR-11-4_006
تاریخ نمایه سازی: 16 تیر 1405
چکیده مقاله:
Background & Objective: Ectopic Pregnancies (EP) account for about ۲% of pregnancies. If diagnosis and treatment are not rapidly performed, it may result in an acute emergency status that can account for about ۶% of pregnancy-related deaths. The present study was conducted with aim to evaluate reproductive outcomes following methotrexate therapy for ectopic pregnancy, including probabilities of spontaneous pregnancy, use of Assisted Reproductive Technology (ART), live birth, abortion, and recurrent Ectopic Pregnancy (EP). Materials & Methods: This retrospective-prospective cohort study was conducted at Shariati Hospital in Tehran, Iran. The outcomes of pregnancy were analyzed in ۱۲۳ women treated with methotrexate for EP. Data collected from hospital records included maternal age, gestational age, parity, smoking status, and medical history. Patients were followed up to assess future pregnancy outcomes, including spontaneous pregnancy, live birth, abortion, recurrent EP, and need for ART. Results: The mean age of women was ۳۱.۳±۶.۰ years and the mean gestational age was ۶.۶±۲.۱ weeks. The average number of prior pregnancies was ۱.۲±۱.۲. Among the participants, ۲۱% had a history of infertility, ۳۳% had prior miscarriages, and ۱۳% had a history of ectopic pregnancies. Over a two-year follow-up, ۴۴% pursued additional pregnancies, ۳۸% conceived naturally, and ۱۸% used Assisted Reproductive Technology (ART). More than half of the pregnancies occurred within ۷ to ۴۸ months after methotrexate treatment, and there were no recurrences of ectopic pregnancy or abortions reported. Conclusion: The findings of this study suggest that experiencing an ectopic pregnancy should not be a cause for concern regarding adverse outcomes in future pregnancies. Women can be reassured that the likelihood of achieving a subsequent pregnancy is favorable within two years after methotrexate treatment for EP.
کلیدواژه ها:
نویسندگان
Marzieh Talebian
Department of Obstetrics and Gynecology, School of Medicine, Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan, Iran
Sedigheh Hosseinimousa
Department of Obstetrics and Gynecology, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :